• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本综合分期(JIS)与改良JIS评分作为肝细胞癌肝切除术后生存预测指标的比较研究。

Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.

作者信息

Luo Kai-Zhong, Itamoto Toshiyuki, Amano Hironobu, Oshita Akihiko, Ushitora Yuichiro, Tanimoto Yoshisato, Ohdan Hideki, Tashiro Hirotaka, Asahara Toshimasa

机构信息

Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.

出版信息

J Gastroenterol. 2008;43(5):369-77. doi: 10.1007/s00535-008-2164-y. Epub 2008 Jul 1.

DOI:10.1007/s00535-008-2164-y
PMID:18592155
Abstract

BACKGROUND

The purpose of the study was to compare the abilities of the JIS and modified JIS (m-JIS) scores to predict survival after hepatectomy for hepatocellular carcinoma (HCC).

METHODS

Data for patients who underwent hepatectomy for HCC at Hiroshima University Hospital between 1986 and 2006 were included. The overall survival and disease-free survival were calculated by the Kaplan-Meier method, and differences between groups were tested by the log-rank test. The statistics of the Akaike information criterion (AIC) were used to show the more appropriate model.

RESULTS

A total of 626 patients were included (male/female, 468/158; mean age, 63.4+/-9.6 years; Child-Pugh class A/B, 524/102; liver damage grade A/B/C, 356/261/9). Mean survival and disease-free survival were 8.04+/-0.39 and 4.69+/-0.32 years, respectively. There was a significant difference in the overall survival rate between JIS scores 1 and 2, and 2 and 3 (P<0.05), but not between scores 0 and 1, or 3 and 4 (P>0.05). Except between m-JIS scores 0 and 1, there was excellent discriminatory ability in overall survival rate between other consecutive groups. Concerning disease-free survival, a significant difference was found only between JIS scores 1 and 2. However, the disease-free survival rate could be well differentiated between m-JIS scores 1 and 2, and 3 and 4. The m-JIS score had a higher discriminatory ability, indicated by a linear trend analysis, and a higher homogeneity likelihood ratio, and lower AIC statistics, than the original JIS score in predicting both overall and disease-free survival.

CONCLUSIONS

The modified-JIS scoring system using liver damage grade is better than the original JIS scoring system in predicting survival after hepatectomy for HCC in Japan.

摘要

背景

本研究旨在比较日本综合评分系统(JIS)和改良日本综合评分系统(m-JIS)预测肝细胞癌(HCC)肝切除术后生存率的能力。

方法

纳入1986年至2006年在广岛大学医院接受HCC肝切除术患者的数据。采用Kaplan-Meier法计算总生存率和无病生存率,组间差异采用对数秩检验。使用赤池信息准则(AIC)统计量来显示更合适的模型。

结果

共纳入626例患者(男/女,468/158;平均年龄,63.4±9.6岁;Child-Pugh A/B级,524/102;肝损伤分级A/B/C级,356/261/9)。平均总生存期和无病生存期分别为8.04±0.39年和4.69±0.32年。JIS评分1与2、2与3之间的总生存率存在显著差异(P<0.05),但0与1、3与4之间无显著差异(P>0.05)。除m-JIS评分0与1之间外,其他连续组间的总生存率具有良好的区分能力。关于无病生存期,仅在JIS评分1与2之间发现显著差异。然而,m-JIS评分1与2、3与4之间的无病生存率可以很好地区分。线性趋势分析表明,m-JIS评分在预测总生存期和无病生存期方面比原始JIS评分具有更高的区分能力、更高的同质性似然比和更低的AIC统计量。

结论

在日本,使用肝损伤分级的改良JIS评分系统在预测HCC肝切除术后生存率方面优于原始JIS评分系统。

相似文献

1
Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.日本综合分期(JIS)与改良JIS评分作为肝细胞癌肝切除术后生存预测指标的比较研究。
J Gastroenterol. 2008;43(5):369-77. doi: 10.1007/s00535-008-2164-y. Epub 2008 Jul 1.
2
Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.改良日本综合分期目前是接受肝切除术的肝细胞癌患者可用的最佳分期系统。
J Gastroenterol. 2006 Mar;41(3):250-6. doi: 10.1007/s00535-005-1751-4.
3
Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.七种预后分期系统在接受肝细胞癌肝切除术患者中的比较。
Hepatogastroenterology. 2007 Jul-Aug;54(77):1534-8.
4
Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.比较临床分期系统对接受大肝切除或小肝切除的肝细胞癌患者生存情况的预测能力。
Eur J Surg Oncol. 2007 May;33(4):480-7. doi: 10.1016/j.ejso.2006.10.012. Epub 2006 Nov 28.
5
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.CLIP、奥田、TNM和JIS分期系统对接受手术的肝细胞癌患者的预测价值评估。
J Gastroenterol Hepatol. 2005 May;20(5):765-71. doi: 10.1111/j.1440-1746.2005.03746.x.
6
Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.使用多变量分析对不同分期系统预测的肝细胞癌患者生存率的比较研究。
Eur J Surg Oncol. 2005 Oct;31(8):882-90. doi: 10.1016/j.ejso.2005.04.016.
7
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).肝细胞癌预后分期系统(CLIP评分):其价值与局限性,以及一种新分期系统——日本综合分期评分(JIS评分)的提案。
J Gastroenterol. 2003;38(3):207-15. doi: 10.1007/s005350300038.
8
The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy.日本采用肝损伤分级的肝切除术后肝细胞癌综合分期评分。
Eur J Surg Oncol. 2004 Sep;30(7):765-70. doi: 10.1016/j.ejso.2004.05.003.
9
A new classification for hepatocellular carcinoma with portal vein tumor thrombus.肝细胞癌伴门静脉癌栓的新分类。
J Hepatobiliary Pancreat Sci. 2011 Jan;18(1):74-80. doi: 10.1007/s00534-010-0314-0.
10
Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis.提出联合日本综合分期系统和肝硬化的肝癌功能状态评估标准。
Int J Oncol. 2015;46(6):2371-9. doi: 10.3892/ijo.2015.2969. Epub 2015 Apr 17.

引用本文的文献

1
Interaction between periodontitis and liver diseases.牙周炎与肝脏疾病之间的相互作用。
Biomed Rep. 2016 Sep;5(3):267-276. doi: 10.3892/br.2016.718. Epub 2016 Jul 18.
2
An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.一种用于根治性肝切除术后肝癌患者的准确预后分期系统。
Int J Oncol. 2015 Mar;46(3):944-52. doi: 10.3892/ijo.2014.2798. Epub 2014 Dec 17.
3
A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.

本文引用的文献

1
Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.共存肝硬化对符合米兰标准的肝细胞癌患者肝部分切除术后结局的影响:293例患者分析
Surgery. 2007 Nov;142(5):685-94. doi: 10.1016/j.surg.2007.05.009.
2
Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors.肝细胞癌的射频消融:长期疗效及预后因素
Eur J Radiol. 2008 Aug;67(2):336-347. doi: 10.1016/j.ejrad.2007.07.007. Epub 2007 Aug 31.
3
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan.
一种新的可切除肝细胞癌分期系统:与中国大样本队列中 6 种现有分期系统的比较。
J Cancer Res Clin Oncol. 2011 May;137(5):739-50. doi: 10.1007/s00432-010-0935-3. Epub 2010 Jul 6.
4
Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma.经导管动脉内灌注化疗顺铂-碘油混悬剂治疗肝细胞癌。
J Gastroenterol. 2010;45(1):60-7. doi: 10.1007/s00535-009-0109-8. Epub 2009 Aug 5.
日本第 17 次原发性肝癌全国随访调查报告。
Hepatol Res. 2007 Sep;37(9):676-91. doi: 10.1111/j.1872-034X.2007.00119.x.
4
Hepatocellular cancer: a guide for the internist.肝细胞癌:内科医生指南
Am J Med. 2007 Mar;120(3):194-202. doi: 10.1016/j.amjmed.2006.11.020.
5
Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.比较临床分期系统对接受大肝切除或小肝切除的肝细胞癌患者生存情况的预测能力。
Eur J Surg Oncol. 2007 May;33(4):480-7. doi: 10.1016/j.ejso.2006.10.012. Epub 2006 Nov 28.
6
A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma.用于肝细胞癌患者预后评估的改良日本综合分期评分
J Gastroenterol. 2006 Sep;41(9):884-92. doi: 10.1007/s00535-006-1878-y.
7
Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.改良日本综合分期目前是接受肝切除术的肝细胞癌患者可用的最佳分期系统。
J Gastroenterol. 2006 Mar;41(3):250-6. doi: 10.1007/s00535-005-1751-4.
8
Comparison of the grade evaluated by "Liver damage" of Liver Cancer Study Group of Japan and Child-Pugh classification in patients with hepatocellular carcinoma.日本肝癌研究组的“肝损伤”分级与肝硬化患者 Child-Pugh 分级的比较。
Hepatol Res. 2006 Apr;34(4):266-72. doi: 10.1016/j.hepres.2005.05.010. Epub 2006 Feb 3.
9
Long-term survival is superior after resection for cancer in high-volume centers.在高容量中心,癌症切除术后的长期生存率更高。
Ann Surg. 2005 Oct;242(4):540-4; discussion 544-7. doi: 10.1097/01.sla.0000184190.20289.4b.
10
Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.日本肝细胞癌三种分期系统(CLIP、BCLC和JIS)实用性的比较。
Am J Gastroenterol. 2005 Aug;100(8):1764-71. doi: 10.1111/j.1572-0241.2005.41943.x.